Cargando…

World Health Organization Approaches to Evaluating the Potential Use and Quality of Hepatitis E Vaccine

Detalles Bibliográficos
Autores principales: Harmanci, Hande, Duclos, Philippe, Rodriguez Hernandez, Carmen A., Meek, Andrew, Balakrishnan, Madhava Ram, Kumar Arora, Narendra, Wiktor, Stefan Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324226/
https://www.ncbi.nlm.nih.gov/pubmed/25734167
http://dx.doi.org/10.1093/ofid/ofu099
_version_ 1782356657534140416
author Harmanci, Hande
Duclos, Philippe
Rodriguez Hernandez, Carmen A.
Meek, Andrew
Balakrishnan, Madhava Ram
Kumar Arora, Narendra
Wiktor, Stefan Z.
author_facet Harmanci, Hande
Duclos, Philippe
Rodriguez Hernandez, Carmen A.
Meek, Andrew
Balakrishnan, Madhava Ram
Kumar Arora, Narendra
Wiktor, Stefan Z.
author_sort Harmanci, Hande
collection PubMed
description
format Online
Article
Text
id pubmed-4324226
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-43242262015-03-02 World Health Organization Approaches to Evaluating the Potential Use and Quality of Hepatitis E Vaccine Harmanci, Hande Duclos, Philippe Rodriguez Hernandez, Carmen A. Meek, Andrew Balakrishnan, Madhava Ram Kumar Arora, Narendra Wiktor, Stefan Z. Open Forum Infect Dis Editorial Commentary Oxford University Press 2014-12-02 /pmc/articles/PMC4324226/ /pubmed/25734167 http://dx.doi.org/10.1093/ofid/ofu099 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
spellingShingle Editorial Commentary
Harmanci, Hande
Duclos, Philippe
Rodriguez Hernandez, Carmen A.
Meek, Andrew
Balakrishnan, Madhava Ram
Kumar Arora, Narendra
Wiktor, Stefan Z.
World Health Organization Approaches to Evaluating the Potential Use and Quality of Hepatitis E Vaccine
title World Health Organization Approaches to Evaluating the Potential Use and Quality of Hepatitis E Vaccine
title_full World Health Organization Approaches to Evaluating the Potential Use and Quality of Hepatitis E Vaccine
title_fullStr World Health Organization Approaches to Evaluating the Potential Use and Quality of Hepatitis E Vaccine
title_full_unstemmed World Health Organization Approaches to Evaluating the Potential Use and Quality of Hepatitis E Vaccine
title_short World Health Organization Approaches to Evaluating the Potential Use and Quality of Hepatitis E Vaccine
title_sort world health organization approaches to evaluating the potential use and quality of hepatitis e vaccine
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324226/
https://www.ncbi.nlm.nih.gov/pubmed/25734167
http://dx.doi.org/10.1093/ofid/ofu099
work_keys_str_mv AT harmancihande worldhealthorganizationapproachestoevaluatingthepotentialuseandqualityofhepatitisevaccine
AT duclosphilippe worldhealthorganizationapproachestoevaluatingthepotentialuseandqualityofhepatitisevaccine
AT rodriguezhernandezcarmena worldhealthorganizationapproachestoevaluatingthepotentialuseandqualityofhepatitisevaccine
AT meekandrew worldhealthorganizationapproachestoevaluatingthepotentialuseandqualityofhepatitisevaccine
AT balakrishnanmadhavaram worldhealthorganizationapproachestoevaluatingthepotentialuseandqualityofhepatitisevaccine
AT kumararoranarendra worldhealthorganizationapproachestoevaluatingthepotentialuseandqualityofhepatitisevaccine
AT wiktorstefanz worldhealthorganizationapproachestoevaluatingthepotentialuseandqualityofhepatitisevaccine